A Pilot Study to Evaluate the Feasibility, Safety, and Efficacy of Cannabigerol/Cannabidiol Oil for Chemotherapy-Induced Peripheral Neuropathy
Objective
Assess the overall safety and tolerability of CBG/CBD oil throughout the entire study duration. Evaluate the feasibility of using CBG/CBD oil to treat patients with CIPN over the first 4-week of treatment cycle.